Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging remimazolam toluenesulfonate sedation trial in elderly patients undergoing painless colonoscopy
ChiCTR2000034549Phase 4Recruiting
- Sponsor
- The First People's Hospital of Shuangliu District, Chengdu
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in nonelective procedural sedation requirement for colonoscopy (3 arms), sponsored by The First People's Hospital of Shuangliu District, Chengdu. Primary endpoint: Effective sedation rate. Started Jun 2020; status: recruiting.
02
Drugs
remimazolam
03
Conditions
nonelective procedural sedation requirement for colonoscopy
Beyond the preview
Go deeper on ChiCTR2000034549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034549.